Northern Trust
BOLT icon

Northern Trust’s Bolt Biotherapeutics BOLT Stock Holding History

Northern Trust’s Portfolio BOLT Stock Details BOLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,045
Closed -$16.4K – 4416
2025
Q1 		$16.4K Hold
2,045
– – ﹤0.01% 4358
2024
Q4 		$21.9K Hold
2,045
– – ﹤0.01% 4368
2024
Q3 		$26.5K Hold
2,045
– – ﹤0.01% 4306
2024
Q2 		$30.7K Sell
2,045
-5
-0.2% -$99 ﹤0.01% 4284
2024
Q1 		$57.4K Hold
2,050
– – ﹤0.01% 4204
2023
Q4 		$45.9K Buy
2,050
+491
+31% +$9.56K ﹤0.01% 4249
2023
Q3 		$32.4K Hold
1,559
– – ﹤0.01% 4251
2023
Q2 		$39.9K Hold
1,559
– – ﹤0.01% 4272
2023
Q1 		$43.3K Sell
1,559
-55
-3% -$1.61K ﹤0.01% 4290
2022
Q4 		$42K Hold
1,614
– – ﹤0.01% 4322
2022
Q3 		$48K Buy
1,614
+545
+51% +$22.6K ﹤0.01% 4331
2022
Q2 		$44K Sell
1,069
-8,240
-89% -$320K ﹤0.01% 4439
2022
Q1 		$510K Sell
9,309
-436
-4% -$29.3K ﹤0.01% 3734
2021
Q4 		$955K Buy
9,745
+406
+4% +$77.1K ﹤0.01% 3555
2021
Q3 		$2.36M Buy
9,339
+3,421
+58% +$967K ﹤0.01% 3197
2021
Q2 		$1.83M Sell
5,918
-761
-11% -$309K ﹤0.01% 3380
2021
Q1 		$4.4M Buy
+6,679
New +$4.35M ﹤0.01% 2836

Other funds holding BOLT

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust's BOLT Position: Q2 2025 in Review

Northern Trust sold out of Bolt Biotherapeutics (BOLT) in Q2 2025, closing a stake of 2,045 shares — an estimated $16.4K sold.

Northern Trust first reported a position in BOLT in Q1 2021 and held it in 17 quarters. The position peaked at $4.4M in Q1 2021. 25 funds tracked by Wall St. Rank hold BOLT as of Q2 2025.

  • Northern Trust reported no remaining Bolt Biotherapeutics position as of Q2 2025 after selling out during the quarter.
  • Northern Trust sold 2,045 Bolt Biotherapeutics shares in Q2 2025, an estimated $16.4K.
  • Northern Trust first reported a position in Bolt Biotherapeutics in Q1 2021 and held it in 17 quarters.
  • Northern Trust's Bolt Biotherapeutics position peaked at $4.4M in Q1 2021.
  • 25 funds tracked by Wall St. Rank held Bolt Biotherapeutics as of Q2 2025.

Based on Northern Trust's 13F filing for Q2 2025, filed 13 Aug 2025.